Topic Archives: healthcare

Comments

  • Avatar

    Idiot. You missed the point completely. The problem is government healthcare and smoking. Free market healthcare and al...

  • Avatar

    I don't think that WIT (Wipro) is the company that is referred to in this teaser ad. I went back and checked the date of...

  • Avatar

    Additional info from his first reference to this announcement last Friday: And while it sounds incredible… This $5 s...

  • Avatar

    Travis, it's OK to be wrong once in a while. From years of following you, I don't remember you saying you could wake on ...

  • Avatar

    When it comes to healthcare and primary care in particular I as a retired healthcare professional have only one prescrip...

  • LongOnLife

    Any "cure" for any potentially fatal disease would be a tremendous blockbuster for the company that develops it. It is t...

  • Avatar

    I'm sensing this socialism/capitalism thing is a hot button that gets some of y'all into a mood for making a whole lot o...

  • Avatar

    Pain is some thing which is difficult to remove. But we takes certain medicine to get rid of it. Our day to day activity...

  • Avatar

    So here is my update and impressions so far. Chuck is a trend trader. When there is a good trend and you follow his ru...

  • Gr8Full!

    BREAKING: That's cash plus $1B-plus 6 months after arriving at Sanofi R&D, John Reed gambles $125M on Denali’s RIPK1 w...

  • Gr8Full!

    #ASH18 abstracts are now online: https://ash.confex.com/ash/2018/webprogram/ … Thank you @Odibro :-) https://twitter.c...

  • Gr8Full!

    #86AD > Mandelblatt cautioned that her study was still too small to reach any conclusion, but if future studies could re...

  • Avatar
  • Avatar

    $ARTH - Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesda...

  • Avatar

    The company is AXTI. Please see this Gumshoe post: https://www.stockgumshoe.com/reviews/radical-technology-profits/s...

  • Avatar

    After buying OKTA shares -- thanks to our Gumshoe's diligence -- I noticed "okta" in the path name (URL) of my healthcar...

  • Avatar

    $ARTH atlas long way to go Arch! long time since latest concrete and good news :) an infection is much more common ca...

  • Avatar

    Yeah too bad hospitals are shutting doors and on the chopping block. Ours is tops in the region, first in kidney, liver...

  • Gr8Full!

    $HALO > Halozyme Therapeutics To Participate In Upcoming Healthcare Conference https://www.halozyme.com/investors/news...

  • Avatar

    Nice summary. I would definitely push weightlifting to increase bone density (wearing a weighted vest during portions o...

  • Gr8Full!

    Three Huge Ways Tech Is Overhauling Healthcare https://singularityhub.com/2018/07/06/three-huge-ways-tech-is-overhaulin...

  • JohnM

    I worry a lot more about biotech companies that can’t raise money than those that can. This $4.5 million will carry AR...

  • Avatar

    Having retraced 65% from mid-year highs in 2017 of $1.09 to $0.36 in Feb 2018 IPATF is certainly on the way up again - t...

  • Avatar

    I misstated the time frame. Late Jan. he had the angioplasty - 3 artery stents. Two weeks ago he suffered a heart attack...

  • Avatar

    Today's release updating LexaGene LexaGene’s Prototype for Better Pathogen Detection Now Capable of Identifying...

  • JohnM

    hipockts, I think you are being much too negative about ARTH management. (I am very OW.) 1. They did explain why they d...

  • Avatar

    I like the thesis on Pinc. Have not looked at financials, but I absolutely think that analytics on patient outcomes and ...

  • Avatar

    re PINC, generally agree it looks like its priced reasonably. Looking at the 10Q, the Working Capital is negative ~120m...

  • Gr8Full!

    $TEUM fp - Pareteum Awarded 3-Year $2.5 Million Agreement Mobile Virtual Network Operator Serves Rural North American...

  • Avatar

    Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018 http://phx.corporate-ir.net/phoenix.z...

  • Gr8Full!

    $APTO WOW > ( $EBIO WOW > https://www.stockgumshoe.com/2016/05/microblog-magical-music-mystery-mining/ ) :-) APTO...

  • Gr8Full!

    $AKAO Duggan on his journey yo own > http://investors.achaogen.com/secfiling.cfm?filingid=921895-18-1425&CIK=1301501 ...

  • Avatar

    Excellent article Doc Gumshoe! We really appreciate all of your efforts to educate us and keep us informed and abrea...

  • Avatar

    Long $MGEN; Brokerage firm Jefferies has been weighing in on a number of healthcare stocks this week. This morning, th...

  • Avatar

    $APTO Laurence Lytton @1.7 million shares, Cormorant Global HealthCare at 824k shares and Franklin Resources (Associated...

  • Avatar

    $VTGN sold after a few red flags including this article Vistagen - Nanocap CNS Drug Chasing Ketamine Fame Mar. 21, 20...

  • Avatar

    $ATHX ow. Maybe we'll have some good results from MultiStem by midyear. We trust there will be a good result treati...

  • Gr8Full!

    $SNDX 20180321 Event Reminder Oppenheimer's 28th Annual Healthcare Conference 3/21/2018 2:45:00 PM ET http://ir.synd...

  • Gr8Full!

    $PTGX 20180321 > Title: Protagonist Therapeutics to Participate in the 28th Annual Oppenheimer Healthcare Conference h...

  • Gr8Full!

    $MGEN 1/2p due to of dry powder - Took a position last Wednesday. This one might be headed northbound. Look at $MGEN ...

  • Avatar

    $ARTH A little background for newbies. We have been following $ARTH since October 2014. CEO of Arch, Terrence Norchi...

  • Gr8Full!

    #HIMSS18: The #Cybersecurity Agenda Cybersecurity will again be in the spotlight at this year's Healthcare Information ...

  • Avatar

    Doc Jorrin Gumshoe hit it out of the park, dead on, so correct and informative I read his column twice. I have been inv...

  • Avatar

    Readers may be interested in looking at the January 2018 JP Morgan Healthcare presentation by SGMO. Their gene editing ...

  • Avatar

    I like instead the company Sangamo (SGMO). Their gene editing technology (zinc finger) appears more robust and safer th...

  • Gr8Full!

    $HALO - 20180316 SAN DIEGO, Feb. 27, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO), a biotechnology company de...

  • Avatar

    From MarketBeat 15 Healthcare Stocks that Analysts Love in 2018 Long $NITE and $SRNE, Nightstar Therapeutics (N...

  • Avatar

    Hedy,- I agree with you 100% on how to govern based on what Trump ran on and i wish things would work that way. But aga...

  • Gr8Full!

    $PTI 8-K - CBO now COO http://ir.proteostasis.com/node/7691/html Item 5.02. Departure of Directors or Certain Officer...

  • Gr8Full!

    $AUPH - 20180214; VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) tod...

  • Gr8Full!

    Nobody knows yet what Amazon, Berkshire Hathaway, and JPMorgan have planned for their new healthcare venture. @matthewhe...

  • Avatar

    $ No ticker Xarelto's patents extend to 2020 and 2024, so no generic before that and possibly even longer if they can...

  • Dr. KSS MD PhD

    Noci: They're having an R&D event in London in about three weeks and I asked if I could attemd. Who gets in is being han...

  • Avatar

    $Welcome Hi Karen, First, allow me to extend to you an informal welcome to the forum. Dr. KSS is currently en rout...

  • Avatar

    $SRNE Long From January 16th Sorrento Therapeutics target raised to $30 at H.C. Wainwright -- Multiple Recent De...

  • Avatar

    $AUPH OW theflyonthewall.com: Aurinia CEO open to takeover if voclosporin succeeds, Dealreporter says Aurinia Pha...

  • Avatar

    Hi Doc, just joined the site. FYI, I post on twitter under BioValue @jstbiotech. Curious, are you still long LPTX? I've ...

  • Avatar

    Author: linling88 Comment: $HALO Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018 PR Newswire...

  • SoGiAm

    #HEMD - #HealthCare Education Matriculation Discount May @StockGumshoe offer subscription discounts to #MedStudents, #N...

  • Avatar

    $ONCS Dont' know what to make of this. On the one hand female directors leaving is a bad sign (especially after just 4...

  • Avatar

    $ISRG NP J.P. Morgan note ISRG: This morning, Intuitive Surgical (ISRG) preannounced very strong preliminary 4Q17...

  • Avatar

    $TGTX (long) - Today's presentation at the J.P. Morgan Healthcare Conference was very well received. The stock is up ab...

  • Avatar

    $ HALO LONG HALO, HALO US Key Takeaways from Inside the J.P. Morgan Healthcare Conference - ALERT Price: $18.66 0...

  • Avatar

    $HALO Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018 PR NewswireJanuary 9, 2018 CONTINUES TO E...

  • SoGiAm

    $NTRP, $VTVT, #AD... The Neuroscience Innovation Forum ​' http://www.sachsforum.com/nif-about.html Building on th...

  • Avatar

    Yeah, I fell for Pail Mamsilly's "profits Unlimited" and have received nothing but a headache. As I am a paraplegic tryi...

  • SoGiAm

    Each week at #DividendChannel, we screen through our coverage universe of dividend paying stocks, and we look at a varie...

  • Avatar

    $VBLT and $SCYX VBLT appoints David Hastings and Susan Kelley, MD to its Board. Hastings also sits on Scynexis Board. D...

  • Avatar

    $ESPR (1) Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference https://gl...

  • SoGiAm

    #Healthcare is hemorrhaging data. #ArtificialIntelligence is here to help via @WIRED http://ow.ly/hc6I30hwzdm #health #...

  • SoGiAm

    CLLS - Cellectis to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 12:00PM P...

  • SoGiAm

    $TRVN np - Trevena Announces FDA Acceptance for Review of New Drug Application for OLINVO(TM) (oliceridine) Injection ...

  • SoGiAm

    #BioTech Calendar Thread: Please REMEMBER to add and review catalysts on the Calendar THREAD as well, so Chip12 can ADD...

  • SoGiAm

    $HALO - 36th Annual J.P. Morgan Healthcare Conference January 9, 2018 06:00 PM EST http://www.halozyme.com/investors/e...

  • Dr. KSS MD PhD

    If your finances allow, I'd consider just sitting on it because a ship will come in one day for Organovo holders....thou...

  • Avatar

    $auph Looking at the Seaport site they cover energy, industrials, chemicals. The head of the healthcare team came in Aug...

  • Avatar

    $HALO #NewSlides (just released) Halozyme Therapeutics (HALO) Presents At BMO Capital Markets 2017 Prescriptions Fo...

  • SoGiAm

    $TRIL - February 14, 2018 at Leerink Partners 7th Annual Global Healthcare Conference http://trilliumtherapeutics.com...

  • SoGiAm

    $NITE long - Nightstar Therapeutics plc at the BMO Capital Markets Prescriptions for Success Healthcare Conference - Con...

  • SoGiAm

    $NITE fp - Is being tossed around like a feather in a storm... What is the deal with this equity? Added more today. :-)...

  • SoGiAm

    $NITE - Dec 14, 2017 at 9:00 AM EST Nightstar Therapeutics plc at the BMO Capital Markets Prescriptions for Success Hea...

  • SoGiAm

    $MBRX 1/2p - Please be advised, the Moleculin Biotech, Inc. (Nasdaq: MBRX) management team including, Walter Klemp, CE...

  • Avatar

    $NITE long The shorts are really trying to drag the stock down. There is a large gap between bid and ask 15.03/15.82. V...

  • Avatar

    $FreeCME HER2-Positive Breast Cancer Since we discuss this often on here, this is a link for any healthcare profession...

  • JohnM

    $ARTH ow, pesh, almost all institutions can invest in ARTH now. Only conservative mutual funds that require a dividend o...

  • SoGiAm

    $INCY, $NVS, $AZN and much more... #JPM18 Will you be in San Francisco on January 9? https://endpts.com/san-francis...

  • Avatar

    $ SCYX New long 13-Dec-17 Conferences Guggenheim 5th Annual Boston Healthcare Conference (SCYX) Add Event...

  • SoGiAm

    $PTGX - Protagonist Therapeutics Inc has added a news release to its Investor Relations website. Title: Protagonist T...

  • Avatar

    $PGTX 04-Dec-2017:08:00:00, Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions for Succe...

  • Avatar

    $PGTX LONG 04-Dec-2017:08:00:00, Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions ...

  • SoGiAm

    #Long - $PRTC.L - Company Completes Large Multi-Center, Randomized, Controlled Study of Novel Digital Medicine and Plan...

  • SoGiAm

    $AKAO 13/12/17 Achaogen to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference SOUTH SA...

  • SoGiAm

    #NBRV Nabriva Therapeutics plc has added a news release to its Investor Relations website. Title: Nabriva Therapeutic...

  • SoGiAm

    Linda invites you to join her 29/11/17 11:50 ET: https://twitter.com/linda_marban/status/935268845039771648 Don't mis...

  • Avatar

    $SRRA perceptive advisors files 7% ownership of Sierra. Point 72 asset mgmt, orbimed advisors, iguana healthcare, percep...

  • SoGiAm

    #IT transformation is much needed in #Healthcare, BUT needed to optimize clinical care & improve patient outcomes. O...

  • Avatar

    $GE $NVDA $AI Revolution In HC “GE and NVIDIA Join Forces to Accelerate Artificial Intelligence Adoption in Hea...

  • arch1

    No ticker Doc Just a quick read of this has altered my thinking and left me with several questions. Don't feel pressure...

  • Avatar

    $TTOO -the latest from a 11/20/17 press release: "[ , , , ,] a leader in the development of innovative diagnostic produc...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch